key: cord-0898053-jathnrfh authors: Yadav, Ramakant; Srivastava, Dhiraj Kumar; Bajpai, Prashant Kumar; Kumar, Raj title: Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients date: 2021-03-23 journal: J Infect Public Health DOI: 10.1016/j.jiph.2021.03.005 sha: 7c55c8ed1db64e966a93f7dc1778188982800862 doc_id: 898053 cord_uid: jathnrfh Coronavirus is known to cause various systemic infections both in human and animal which are mostly mild in nature. However, recent years have seen major pandemics caused by coronavirus which are very invasive and virulent in nature. The recent SARS-CoV2 is a new addition to this list of coronavirus pandemics. So the present study was done to systematically review the CNS involvement and its manifestations in SARS-CoV2 positive patients. Systemic review of article published between 1st Dec 2019 to 31st July 2020 searched through web-based database of MEDLINE (Pubmed) and Google scholar using following keywords “COVID -19” OR “CORONAVIRUS” OR “SARS-CoV2” AND “NEUROLOGICAL” OR “CNS” OR “BRAIN”. Using the steps of systemic review eight article were selected for qualitative analysis. Majority of these article were reporting neurological symptoms among patients admitted in different wards along with others general symptoms. None of the study was specifically devoted to study the neurological manifestations and complications in SARS-CoV2 positive patients. The present study concludes that there is a scarcity of good quality research which attempts to establish the role of SARS-CoV2 infection in CNS and its manifestations. However, there are evidences that CNS involvement is present in majority of the patients. Proper documentation of theses involvement and indentification of these into mild, moderate and severe infection will help in early identification and treatment of these patients Due to its resemblance with the SARS, both in terms of clinical symptoms and the fact that both share same receptors, Angiotensin Converting Enzyme -2(ACE-2), it was named as SARS-CoV2 in February. However, World Health Organization (WHO) has renamed it as Corona virus Disease 2019 (COVID-19). (5) Corona virus infection are known to be invasive in nature with its primary target being the lower respiratory tract cells, thus presenting with the symptoms of Lower respiratory infections leading to severe acute respiratory distress syndrome. In the initial incubation period, virus replicate in the mucosal cells located in the peripheral lung field. In the clinical phase when the virus load crosses the critical level, lung damage take place leading to fever, cough and shortness of breath. The virus also has potential to invade neurological tissue. (6) There are three probable route for the neuronal invasion namely:-Direct Inoculation, Blood circulation pathway and Neuronal pathway via a olfactory bulb. However, most probable route of infection is thought to be through olfactory bulb, causing inflammation and demyelination. (5) In the present study we will discuss the Nervous System involvement and its manifestation in COVID -19 patients. The present study was conducted according to the Preferred Reporting Item for Systemic Review and Meta Analysis(PRISMA) guidelines. Electronic database Medline (Pubmed) and Google Scholar were searched systematically for published articles from 1 st Dec 2019 to 31 st July 2020 using following keywords: "COVID -19" OR "CORONAVIRUS DISEASE" OR "SARS-CoV2" AND "NEUROLOGICAL" OR "CNS MANIFESTATIONS" OR "BRAIN". The authors also searched references included in the selected articles to ensure sufficient literature to be available for review. Authors 1 st listed all the articles searched using electronic database-Medline and Google Scholar and from references of the selected articles. Only articles whose main text are available in English language were included in the study. After the listing, authors screened the articles based on the title and abstract of the article. In the 1 st step, a total of 180 article were listed. Out of this, 97 articles were removed as their title did J o u r n a l P r e -p r o o f not match with the study objectives. 26 articles were further excluded because their main texts were not available in English language. In the second step authors retrieved the full text of the shortlisted article of the 1 st step. Full text of the selected articles were reviewed first for the objectives of the study, study methodology, data collection process and limitations of the study. Thus, 57 out of shortlisted in the 1 st step, full text of 54 articles were retrieved for further review. Full text of three articles could not be retrieved as they were not available for review at the time of writing the paper. Out of remaining 54 articles, 22 articles were excluded as they were duplicate articles. 11 articles were further excluded as their data collection process were not appropriate or dubious. Thus a final list of 21 articles was prepared and following information were extracted from the selected studies: study design, main result and limitations of study. symptoms. Also some case reports are also available which suggest positive CSF findings in COVID-19. One of the case reports also suggest EEG changes in corona positive (9) . It is noted in the present study that neurological manifestations are common in current COVID-19 positive pandemic. Corona virus are commonly found in both human and animals , but occasionally it cross the species barrier and cause serious pandemics and latest pandemic is an example of this crossing over. It has a huge on the society financial and non financial terms. (2, 28) J o u r n a l P r e -p r o o f On doing qualitative analysis of the finalized articles, it was noted that there is scarcity of specific studies dedicated to study neurological involvement in COVID-19 patients and to established its association and the time line of neurological involvement in COVID-19 patients . Till then the findings of previous coronavirus pandemics can also be safely applied on the current SARS-CoV2 pandemic .(29) In 2003, SARS-CoV epidemic, patients with neurological manifestation had their CSF positive for the virus. (3) In study of patients suffering for MERS, neurological manifestation was also reported in few patients. (30, 31) So, it's quite imperative to presume that the current pandemic will also have patients presenting with different neurological manifestations. Some of these manifestations will be specific like cerebrovascular accidents, seizures, meningitis, encephalitis whereas majority will have nonspecific symptoms like confusion, dizziness, headache, myalgia. Studies done using retrospective data analysis of COVID-19 patients has shown that patients may have few symptoms of central nervous system involvement like headache, confusion, dizziness, and cerebrovascular accidents. (7-13, 17, 20, 22,23) Symptoms like loss of taste and smell are signs of peripheral nervous system involvement. (26) However some patients may present with few symptom complexes like Guillain-Barré Syndrome, miller-Fisher syndrome etc. (18, 19) Various mechanism has been proposed for the neuronal damages in COVID-19 patients like direct infection injuries, hypoxic injuries and immune mediated. symptoms are later found to be COVID-19 positive. (34) CNS involvement mostly take place in the second week of the infection due to hypoxic injuries. Thus leading to decrease oxygen saturation in the blood, this further lead to anerobic metabolism in the mitochondria of the brain cells and accumulation of the acid in the neuronal tissues resulting in cerebral vasodilation, swelling of brain cells, interstitial edema, obstruction to blood flow leading to ischemia which result in headache and dizziness. (35) In severe cases, there is a raised intracranial tension which result in drowsiness, bulbar conjunctival edema and even coma. In patients who are prone to cerebrovascular accidents, hypoxia result in cerebral stroke via a release of cytokine storms which mostly happen in second week. Is through immune mediation. (36) Another mechanism related to the CNS manifestation. Recent months have seen some cases of COVID-19 being progressed to Chronic COVID Syndrome which ave been referred to as Long Hauler Syndrome in the updated literature (38) (39) . Though the exact mechanism of this progression is still unknown, it is hypothesized that incomplete removal of the viral antigen plays a key role in its development. Incomplete removal of the viral antigen could be due to defective immune response or due to presence of specific HLA subtype. Therefore, persons with Chronic COVID Syndrome with Long Hauler should be screened to identify HLA subtype associated with the chronic progression of the disease. Similar reasons have also been suggested for the asymptomatic patients who does not develop the disase but still continue to spread the disease. Most cases present with headache, fever, vomiting and convulsions. In a case report by Xiang et al, reported a case of viral enchaplitis with positive CSF for viral protein. (12) However, in a case report by Saiegh et al, reported two COVID 19 positive patients with neurological manifestations but their CSF were not positive for the viral protein. (14) This indicate that there is scope for future studies to confute or refute the presence of viral enchapalits due to COVID 19 infections. In addition to this, hemorrhagic posterior reversible encephalopathy syndrome, and acute necrotizing encephalopathy, including the brainstem and basal ganglia, paralysis. (42) (43) (44) As the COVID -19 positive patients develop severe hypoxia during the course of the disease, they are prone to Infectious Toxic Encephalopathy (Guo etal) . (35) This is further supported by the autopsy finding of COVID-19 patients which shows signs of cerebral edema in brain tissues. (Xu et al) (45) Neurological damages can be classified into temporary or permanent neurological damages. Majority of the patients may present with the symptoms of temporary damages in the form of brain fog, confusion, stiffness of limbs etc which may resolve as the disease progress. However, some may present with symptoms of permanent damages like decline in the cognitive function etc. especially in patients with Chronic COVID Syndrome with Long Hauler. Majority of these patients have chronic low grade inflammation in the neuronal tissue resulting in the loss of neuronal and glial cells which are responsible for the normal functioning of the nervous system. Another mechanism that has been proposed for the permanent damage has been the loss of above cells due to budding of new viron in them. Present pandemic has shown that there is limited information available as far as the pathophysiology of the disease is concern. It provides lot of opportunity for future research. Major areas where dedicated research required are:  At molecular level to understand the mechanism of the disease involvement and its progression. Research is required to understand why some people develop the disease and while some do not. We also need to understand why in some person the rate of disease progration is very fast while in some it is not. The present study concludes that there is a scarcity of good quality research which specifically focus on neurological involvements in COVID19 patients. Also, the present study concludes that there is enough evidence to prove that SARS-CoV2 infection affect neurological tissues both in central and peripheral nervous system. Various mechanisms are proposed to explain the pathophysiology of neurological manifestations in COVID 19 positive patients which need to be established and verified. This should be supplemented with Biochemical and Electro-physiological studies. The authors of the study also concludes that there is an urgent need to focus on the chronology of the CNS involvement and its syndromic management as establishing the chronology of the disease will help in early identification of the disease. This will help in effective treatment and reduction in the severity of the disease. However, the present study also concludes that some patients, especially those with severe infection, may have clinical and subclinical neurological manifestation which can be assign to impaired electrolyte and metabolic derangement. This should also be considered while evaluating patients with neurological manifestations. J o u r n a l P r e -p r o o f Outbreak: 10 of the worst pandemic in history Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System Neurologic alterations due to respiratory virus infections Neurologic complications of coronavirus infections Coronavirus infection of the central nervous system: hostvirus stand-off Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a Retrospective Case Series Study Acute Cerebrovascular Disease Following COVID-19: A Single Center Clinical features of patients infected with 2019 novel coronavirus in Wuhan Neurologic Features in Severe SARS-CoV-2 Infection Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. General Hospital Psychiatry First case of 2019 novel coronavirus disease with encephalitis Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. bmj Guillain-Barré syndrome associated with SARS-CoV-2 Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 Large-vessel stroke as a presenting feature of Covid-19 in the young Prevalence and duration of acute loss of smell or taste in COVID-19 patients Clinical characteristics of coronavirus disease 2019 in China Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Du Pasquier R. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study Macrothrombosis and stroke in patients with mild Covid-19 infection Suppl-2, M5: Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health. The open virology journal State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia Japanese Encephalitis Virus Exploits Dopamine D2 Viral diseases of the central nervous system Early recovery following new onset anosmia during the COVID-19 pandemic -an observational cohort study The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome Acute encephalopathy associated with influenza and other viral infections Septic encephalopathy and septic encephalitis Encephalopathy of infection and systemic inflammation Pathological findings of COVID-19 associated with acute respiratory distress syndrome Pathological findings of COVID-19 associated with acute respiratory distress syndrome